Target
L-lactate dehydrogenase B chain
Ligand
BDBM488263
Substrate
n/a
Meas. Tech.
Inhibition of LDHB Activity
IC50
<100±n/a nM
Citation
 Hall, MUrban, DJKnight, JHolmes, RWood, KDWaterson, ADarley-Usmar, VMNeckers, LM Treating primary or idiopathic hyperoxaluria with small molecule inhibitors of lactate dehydrogenase US Patent  US11752138 Publication Date 9/12/2023
Target
Name:
L-lactate dehydrogenase B chain
Synonyms:
L-lactate dehydrogenase B | L-lactate dehydrogenase B chain | LDH heart subunit | LDH-B | LDH-H | LDHB | LDHB_HUMAN | Lactate dehydrogenase B (LDHB) | Renal carcinoma antigen NY-REN-46
Type:
Oxidoreductase; homotetramer
Mol. Mass.:
36635.55
Organism:
Homo sapiens (Human)
Description:
n/a
Residue:
334
Sequence:
MATLKEKLIAPVAEEEATVPNNKITVVGVGQVGMACAISILGKSLADELALVDVLEDKLKGEMMDLQHGSLFLQTPKIVADKDYSVTANSKIVVVTAGVRQQEGESRLNLVQRNVNVFKFIIPQIVKYSPDCIIIVVSNPVDILTYVTWKLSGLPKHRVIGSGCNLDSARFRYLMAEKLGIHPSSCHGWILGEHGDSSVAVWSGVNVAGVSLQELNPEMGTDNDSENWKEVHKMVVESAYEVIKLKGYTNWAIGLSVADLIESMLKNLSRIHPVSTMVKGMYGIENEVFLSLPCILNARGLTSVINQKLKDDEVAQLKKSADTLWDIQKDLKDL
  
Inhibitor
Name:
BDBM488263
Synonyms:
2-[5-(cyclopropylmethyl)-4-[(3- fluoro-4-sulfamoylphenyl) methyl]-3-[3-(5-isopropylpyridin- 2-yl)phenyl]pyrazol-1-yl]-1,3- thiazole-4-carboxylicacid | US10954228, Compound 218 | US11752138, Compound 218
Type:
Small organic molecule
Emp. Form.:
C32H30FN5O4S2
Mol. Mass.:
631.74
SMILES:
CC(C)c1ccc(nc1)-c1cccc(c1)-c1nn(c(CC2CC2)c1Cc1ccc(c(F)c1)S(N)(=O)=O)-c1nc(cs1)C(O)=O
Structure:
Search PDB for entries with ligand similarity: